At3g60960 Antibody

What is At3g60960 and why are antibodies against it important for plant research?

At3g60960 is the gene identifier for Actin-7 in Arabidopsis thaliana, a critical component of the plant cytoskeleton. Actin-7 has been identified across animals, plants, and protists, playing essential roles in cellular architecture and developmental processes. Antibodies against Actin-7 are vital research tools because they allow visualization and quantification of this protein during plant development, hormone responses, and stress conditions. The ACT7 gene is rapidly and strongly induced in response to exogenous auxin (a plant hormone), making it particularly important for studying hormone signaling pathways . These antibodies enable researchers to track changes in cytoskeletal organization during cell division, expansion, differentiation, and organ initiation - all processes regulated by auxin and dependent on proper actin dynamics.

What types of At3g60960 antibodies are currently available for research?

Currently, researchers have access to several mouse monoclonal antibodies generated against Arabidopsis thaliana Actin-7. Notable clones include 29G12.G5.G6, 33E8.C11.F5.D1, and 36H8.C12.H10.B6, all of which are IgG isotype and purified using Protein G . These antibodies have been tested specifically in A. thaliana with potential cross-reactivity to other species, though this requires validation for each research application. The antibodies are typically supplied in PBS buffer containing 0.05% sodium azide . These monoclonal antibodies have been validated for Western blotting, ELISA, and immunofluorescence applications, providing researchers with versatile tools for investigating Actin-7 expression and localization.

How does Actin-7 function differ from other actin isoforms in plants?

Actin-7 serves distinct functions compared to other actin isoforms in plants, particularly in its responsiveness to environmental and hormonal stimuli. Unlike some constitutively expressed actins, the ACT7 gene is expressed in rapidly developing tissues and responds dynamically to external stimuli, such as exposure to hormones . This makes it a critical player in plant development and adaptation. Actin-7 is specifically required for callus tissue formation and is essential for germination and root growth, suggesting specialized roles in tissue regeneration and early development . The promoter and protein product of the ACT7 gene are rapidly and strongly induced in response to exogenous auxin, indicating a unique role in auxin-mediated growth responses compared to other actin isoforms that may not show such hormone sensitivity.

What are the optimal conditions for using At3g60960 antibodies in Western blotting?

For optimal Western blotting results with At3g60960 (Actin-7) antibodies, researchers should consider several critical parameters. Sample preparation should include a protease inhibitor cocktail to prevent degradation of the Actin-7 protein. A 10-12% SDS-PAGE gel is recommended for optimal separation, as Actin-7 has a molecular weight of approximately 42 kDa . After transfer to nitrocellulose or PVDF membranes, blocking should be performed with 5% non-fat milk or BSA in TBST for 1 hour at room temperature.

Primary antibody incubation should be conducted at dilutions of 1:1000 to 1:5000 (optimized through titration experiments) in blocking buffer overnight at 4°C. Following washing steps with TBST, a compatible secondary antibody (anti-mouse IgG) conjugated with HRP should be applied at a 1:5000 to 1:10000 dilution for 1 hour at room temperature. Detection can be performed using enhanced chemiluminescence reagents. For quantitative Western blots, researchers should include appropriate loading controls and perform at least three biological replicates to ensure reproducibility.

How can I optimize immunofluorescence protocols for Actin-7 detection in plant tissues?

Optimizing immunofluorescence protocols for Actin-7 detection requires careful attention to tissue fixation and permeabilization methods. For Arabidopsis tissues, a recommended fixation protocol involves 4% paraformaldehyde in PBS (pH 7.4) for 1-2 hours, followed by washing in PBS. Permeabilization should be performed using 0.1-0.5% Triton X-100 for 15-30 minutes to allow antibody access to the cytoskeleton while preserving cellular structure.

For primary antibody incubation, dilutions between 1:100 and 1:500 in blocking buffer (3% BSA in PBS) should be tested, with incubation times of 2 hours at room temperature or overnight at 4°C . Fluorophore-conjugated secondary antibodies (anti-mouse) should be applied at dilutions of 1:200 to 1:500 for 1 hour at room temperature in the dark. Counterstaining with DAPI (1 μg/ml) helps visualize nuclei, while phalloidin conjugates can be used as a control for general F-actin visualization. Confocal microscopy with appropriate laser settings is recommended for high-resolution imaging of Actin-7 localization patterns. Negative controls (secondary antibody only) and positive controls should be included in each experiment to verify specificity.

What approaches can be used to study Actin-7 dynamics during auxin response?

To study Actin-7 dynamics during auxin response, researchers can employ multiple complementary approaches. Time-course experiments can be designed where Arabidopsis seedlings are treated with physiologically relevant concentrations of auxin (typically 0.1-10 μM IAA or NAA) for various durations (15 minutes to 24 hours). Samples can then be collected at defined intervals for protein extraction and Western blot analysis using At3g60960 antibodies to quantify changes in Actin-7 protein levels .

For visualizing dynamic rearrangements of the actin cytoskeleton, immunofluorescence microscopy with Actin-7 specific antibodies can be performed on fixed tissues at different time points after auxin treatment. Live-cell imaging approaches can complement these fixed-tissue studies by using fluorescently tagged Actin-7 constructs expressed under native or inducible promoters. Co-immunoprecipitation experiments using At3g60960 antibodies can identify auxin-dependent protein interaction partners. Additionally, researchers can perform gene expression analyses (qRT-PCR, RNA-seq) in parallel to correlate changes in ACT7 transcript levels with protein abundance and cytoskeletal reorganization. Pharmacological approaches using cytoskeleton-disrupting agents (like latrunculin B or cytochalasin D) can help distinguish Actin-7-specific functions from those of other actin isoforms during auxin response.

How can I address cross-reactivity issues with At3g60960 antibodies?

Cross-reactivity is a common challenge when working with antibodies against highly conserved proteins like actins. To address potential cross-reactivity issues with At3g60960 antibodies, researchers should first validate antibody specificity using multiple approaches. Western blot analysis comparing wild-type plants with act7 mutants can confirm specificity for the Actin-7 isoform. If mutants are unavailable, overexpression of tagged Actin-7 can serve as a positive control.

Pre-absorption experiments can reduce non-specific binding by incubating the antibody with purified competing proteins prior to application. For immunocytochemistry applications, parallel staining with different Actin-7 antibody clones (such as 29G12.G5.G6 and 33E8.C11.F5.D1) can help confirm specific labeling patterns . Researchers should also perform blocking peptide competition assays where the immunizing peptide is used to sequester the antibody prior to staining. When working with species other than Arabidopsis, sequence alignment of the epitope regions should be performed to predict potential cross-reactivity. Finally, alternative detection methods like RNA in situ hybridization or transcript-specific probes can complement antibody-based approaches when isoform specificity is crucial.

What strategies can overcome low signal intensity in Actin-7 detection?

Low signal intensity can significantly hamper research progress when working with At3g60960 antibodies. To overcome this challenge, several optimization strategies can be employed. For Western blotting, increasing protein loading (up to 50-100 μg per lane) and extending primary antibody incubation times (overnight at 4°C) can enhance signal detection. Using more sensitive detection methods, such as enhanced chemiluminescence substrates or fluorescent secondary antibodies with digital imaging systems, can also improve signal-to-noise ratios.

For immunofluorescence applications, signal amplification systems like tyramide signal amplification (TSA) or multiple-layer antibody approaches (biotin-streptavidin systems) can significantly boost signal intensity. Optimization of tissue fixation and antigen retrieval protocols is also critical, as overfixation can mask epitopes while underfixation may compromise tissue integrity. Fresh antibody aliquots should be used, as repeated freeze-thaw cycles can reduce antibody activity. Finally, researchers should consider the developmental stage and physiological conditions of their plant material, as Actin-7 expression levels vary significantly with tissue type, developmental stage, and response to hormones like auxin .

How can I differentiate between phosphorylated and non-phosphorylated forms of Actin-7?

Differentiating between phosphorylated and non-phosphorylated forms of Actin-7 requires specialized approaches beyond standard antibody detection. Researchers should consider using phospho-specific antibodies that recognize specific phosphorylation sites on Actin-7, though these may need to be custom-generated if not commercially available. Alternatively, two-dimensional gel electrophoresis can separate protein isoforms based on both molecular weight and isoelectric point, allowing visualization of phosphorylated variants that typically show acidic shifts.

Phos-tag SDS-PAGE is another powerful technique where phosphorylated proteins show reduced mobility compared to their non-phosphorylated counterparts. This can be followed by Western blotting with At3g60960 antibodies to specifically detect Actin-7 isoforms. Mass spectrometry approaches following immunoprecipitation with At3g60960 antibodies can provide definitive identification of phosphorylation sites and their stoichiometry. Functional studies can complement these approaches by using phosphomimetic (S/T to D/E) or phospho-null (S/T to A) mutations in Actin-7 to assess the impact of specific phosphorylation events on protein function, localization, and interaction partners during processes like auxin response.

How can At3g60960 antibodies be employed in studying plant stress responses?

At3g60960 antibodies provide powerful tools for investigating the role of Actin-7 in plant stress responses. Researchers can design experiments exposing Arabidopsis or other plant species to various abiotic stressors (drought, salt, temperature extremes, oxidative stress) or biotic challenges (pathogens, herbivores) followed by immunoblotting to assess changes in Actin-7 protein levels. Immunofluorescence microscopy using these antibodies can reveal stress-induced reorganization of the actin cytoskeleton, which often occurs during adaptive responses.

Co-immunoprecipitation experiments using At3g60960 antibodies can identify stress-specific interaction partners that may regulate cytoskeletal dynamics under adverse conditions. Chromatin immunoprecipitation (ChIP) assays using antibodies against transcription factors combined with qPCR targeting the ACT7 promoter can elucidate transcriptional regulation mechanisms during stress. Translating these approaches to crop species can provide valuable insights for agricultural applications, though researchers should first validate antibody cross-reactivity with the target species' Actin-7 protein. Combining these antibody-based approaches with genetic resources (act7 mutants, overexpression lines) can establish causal relationships between Actin-7 dynamics and stress tolerance phenotypes.

What methods can be used to study the interaction between Actin-7 and auxin signaling components?

Investigating interactions between Actin-7 and auxin signaling components requires sophisticated methodological approaches. Co-immunoprecipitation (Co-IP) using At3g60960 antibodies can pull down Actin-7 complexes, which can then be analyzed by mass spectrometry to identify auxin-dependent interaction partners. This approach can be enhanced by comparing protein interactions before and after auxin treatment to identify dynamic, hormone-responsive associations.

Proximity ligation assays (PLA) offer an in situ approach to visualize protein-protein interactions at the subcellular level, requiring At3g60960 antibodies and antibodies against suspected interacting auxin signaling components. Bimolecular fluorescence complementation (BiFC) and Förster resonance energy transfer (FRET) can complement antibody-based approaches by confirming direct interactions in living cells. Genetic approaches crossing actin7 mutants with auxin signaling mutants (e.g., tir1, arf, aux/iaa) can reveal functional relationships through phenotypic analysis . Pharmacological experiments combining auxin treatments with actin-disrupting drugs can help dissect the cause-effect relationship between auxin signaling and cytoskeletal remodeling. Finally, in vitro binding assays using purified Actin-7 and auxin signaling components can establish the biochemical parameters (affinity, kinetics) of these interactions.

How can advanced imaging techniques enhance the utility of At3g60960 antibodies?

Advanced imaging techniques significantly extend the research applications of At3g60960 antibodies beyond conventional microscopy. Super-resolution microscopy methods, including structured illumination microscopy (SIM), stimulated emission depletion (STED), and single-molecule localization microscopy (PALM/STORM), can resolve Actin-7 organization at the nanoscale level (20-100 nm resolution), revealing detailed cytoskeletal architectures not visible with confocal microscopy.

Live-cell super-resolution imaging using nanobodies derived from conventional At3g60960 antibodies can track dynamic rearrangements of the actin cytoskeleton during developmental processes or in response to environmental stimuli. Correlative light and electron microscopy (CLEM) combines the specificity of immunofluorescence using At3g60960 antibodies with the ultrastructural context provided by electron microscopy. Expansion microscopy physically enlarges specimens after immunolabeling, providing an alternative approach to achieve super-resolution images with standard confocal microscopes. Light-sheet microscopy enables imaging of larger specimens (whole seedlings, organ primordia) with reduced photobleaching, allowing long-term observation of Actin-7 dynamics in developing tissues. Integrating these advanced imaging approaches with computational image analysis can quantify subtle changes in Actin-7 organization that may correlate with specific cellular functions during plant development and stress responses.

How should researchers quantify and statistically analyze Actin-7 expression patterns?

Quantitative analysis of Actin-7 expression patterns requires rigorous methodological approaches and appropriate statistical frameworks. For Western blot analyses, densitometry should be performed using software like ImageJ, normalizing Actin-7 band intensities to appropriate loading controls (not other actins, due to potential cross-reactivity). At least three biological replicates should be analyzed, with technical duplicates for each sample.

For immunofluorescence quantification, parameters such as fluorescence intensity, filament density, orientation, and bundling can be measured using specialized software like FilamentTracker or CytoSpectre. When analyzing expression across different tissues or treatments, researchers should use appropriate statistical tests based on data distribution (parametric or non-parametric). ANOVA followed by post-hoc tests is suitable for comparing multiple groups, while t-tests or Mann-Whitney tests can compare two conditions. Correlation analyses can identify relationships between Actin-7 levels and physiological parameters, particularly in hormone response studies. Researchers should report effect sizes alongside p-values to indicate biological significance, and clearly specify sample sizes, statistical tests, and p-value thresholds in publications. Machine learning approaches can be valuable for complex pattern recognition in Actin-7 organization, particularly when analyzing large datasets from high-content imaging experiments.

What controls are essential when working with At3g60960 antibodies?

Proper experimental controls are crucial for generating reliable and interpretable data with At3g60960 antibodies. For specificity controls, researchers should include Actin-7 knockout or knockdown plants (act7 mutants) alongside wild-type samples. If mutants are unavailable, RNAi lines with reduced Actin-7 expression can serve as alternative negative controls.

Positive controls should include samples known to express high levels of Actin-7, such as rapidly growing tissues or auxin-treated seedlings . For immunolocalization studies, secondary antibody-only controls are essential to assess background fluorescence, while pre-immune serum can help evaluate non-specific binding. Peptide competition assays, where the antibody is pre-incubated with the immunizing peptide before application, can confirm binding specificity. When making quantitative comparisons across conditions, loading controls for Western blots must be carefully selected—ideally proteins unrelated to the cytoskeleton whose expression remains stable under experimental conditions. For cross-species applications, sequence alignment of the epitope region should be performed to predict reactivity, and initial validation experiments should include positive controls from Arabidopsis. Technical replicates address methodological variability, while biological replicates (different plants or independent experiments) account for biological variation.

How can contradictory results between transcript and protein levels of Actin-7 be reconciled?

Discrepancies between Actin-7 transcript and protein levels are common in plant research and require careful interpretation. Post-transcriptional regulation mechanisms, including mRNA stability, translation efficiency, and protein turnover rates, can cause these differences. Researchers should design time-course experiments measuring both transcript (via qRT-PCR) and protein levels (via Western blotting with At3g60960 antibodies) to determine whether there is simply a temporal delay between mRNA expression and protein accumulation.

Polysome profiling can assess translation efficiency of ACT7 transcripts under different conditions, potentially explaining discrepancies when mRNA is present but protein levels remain low. Protein stability assays using cycloheximide to block new protein synthesis can determine if differences result from altered Actin-7 turnover rates. Researchers should consider that different detection methods have varying sensitivities—Western blotting may not detect low abundance proteins that are still functionally significant. Subcellular fractionation followed by immunoblotting can determine if changes in protein localization rather than total abundance are occurring. When publishing seemingly contradictory results, researchers should clearly discuss potential regulatory mechanisms explaining the discrepancies and acknowledge the limitations of each detection method. Finally, complementary functional assays assessing Actin-7 activity or cytoskeletal organization can provide context for interpreting transcript-protein disparities.